Evidence map›Paper›PMID 27927929›Full record

ArticleJournal of clinical microbiology2017

High-Throughput Next-Generation Sequencing of Polioviruses.

Anna M Montmayeur, Terry Fei Fan Ng, Alexander Schmidt, Kun Zhao, Laura Magaña, Jane Iber, Christina J Castro, Qi Chen, Elizabeth Henderson, Edward Ramos and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. High-throughput Sequencing in Vaccine Research.Journal of veterinary research · 2021
    Article
  19. Multiple Respiratory Syncytial Virus Introductions Into a Neonatal Intensive Care Unit.Journal of the Pediatric Infectious Diseases Society · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 3 countries.

Anna M MontmayeurCSRA International, Atlanta, Georgia, USA.
Terry Fei Fan NgDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA ylz9@cdc.gov.ORCID 0000-0002-4815-8697
Alexander SchmidtIHRC, Atlanta, Georgia, USA.
Kun ZhaoDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Laura MagañaOak Ridge Institute for Science and Education, Oak Ridge, Tennessee, USA.
Jane IberDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Christina J CastroOak Ridge Institute for Science and Education, Oak Ridge, Tennessee, USA.
Qi ChenDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Elizabeth HendersonDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Edward RamosCSRA International, Atlanta, Georgia, USA.
Jing ShawDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Roman L TatusovCSRA International, Atlanta, Georgia, USA.
Naomi Dybdahl-SissokoDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Marie Claire Endegue-ZangaCentre Pasteur du Cameroon, Yaoundé, Cameroon.
Johnson A AdenijiDepartment of Virology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
M Steven ObersteDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Cara C BurnsDivision of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Centers for Disease Control and Prevention · USSRA International (United States) · USOak Ridge Associated Universities · USCentre Pasteur du Cameroun · CMUniversity of Ibadan · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The poliovirus (PV) is currently targeted for worldwide eradication and containment. Sanger-based sequencing of the viral protein 1 (VP1) capsid region is currently the standard method for PV surveillance. However, the whole-genome sequence is sometimes needed for higher resolution global surveillance. In this study, we optimized whole-genome sequencing protocols for poliovirus isolates and FTA cards using next-generation sequencing (NGS), aiming for high sequence coverage, efficiency, and throughput. We found that DNase treatment of poliovirus RNA followed by random reverse transcription (RT), amplification, and the use of the Nextera XT DNA library preparation kit produced significantly better results than other preparations. The average viral reads per total reads, a measurement of efficiency, was as high as 84.2% ± 15.6%. PV genomes covering >99 to 100% of the reference length were obtained and validated with Sanger sequencing. A total of 52 PV genomes were generated, multiplexing as many as 64 samples in a single Illumina MiSeq run. This high-throughput, sequence-independent NGS approach facilitated the detection of a diverse range of PVs, especially for those in vaccine-derived polioviruses (VDPV), circulating VDPV, or immunodeficiency-related VDPV. In contrast to results from previous studies on other viruses, our results showed that filtration and nuclease treatment did not discernibly increase the sequencing efficiency of PV isolates. However, DNase treatment after nucleic acid extraction to remove host DNA significantly improved the sequencing results. This NGS method has been successfully implemented to generate PV genomes for molecular epidemiology of the most recent PV isolates. Additionally, the ability to obtain full PV genomes from FTA cards will aid in facilitating global poliovirus surveillance.

Indexed as

High-Throughput Nucleotide SequencingHumansMolecular EpidemiologyPilot ProjectsPoliovirusSpecimen Handlingcell cultureFTA cardsmetagenomicsnext-generation sequencingpicornaviruspoliovirus

Identifiers

PMID27927929
PMCPMC5277531
OpenAlexW2559773799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.